HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kelly Guerrettaz Selected Research

Monoclonal Antibodies

8/2014A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kelly Guerrettaz Research Topics

Disease

1Rheumatoid Arthritis
08/2014
1Rheumatic Diseases (Rheumatism)
08/2014
1Type 2 Diabetes Mellitus (MODY)
01/2013

Drug/Important Bio-Agent (IBA)

1tabalumabIBA
08/2014
1Monoclonal AntibodiesIBA
08/2014
1C-Reactive ProteinIBA
08/2014
1B-Cell Activating FactorIBA
08/2014
1Exenatide (Byetta)FDA Link
01/2013
1Hemoglobins (Hemoglobin)IBA
01/2013
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2013
1Delayed-Action PreparationsIBA
01/2013